Xenetic Biosciences

XBIO70

Penny Stock

$4.26arrow_drop_up2.07%$0.08

Penny Stock

XBIO70

$4.26

arrow_drop_up2.07%$0.08

Penny Stock

Performance History

Key Stats
Open	$4.02
Prev. Close	$4.01
EPS	-2.66
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$6.33M
PE Ratio	-

	LOW	HIGH
Day Range	3.89	4.16
52 Week Range	2.78	5.20

Ratios







EPS	-2.66

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc (XBIO) is a biopharmaceutical company focused on advancing the development of innovative therapeutic products for a range of diseases. With a commitment to improving patient outcomes, Xenetic Biosciences is dedicated to revolutionizing the way diseases are treated.

One key factor that investors may consider when evaluating a stock is its price history. In the case of Xenetic Biosciences, tracking the company's stock price over time can provide valuable insight into its performance. By analyzing historical data, investors can identify trends and patterns that may impact future stock performance.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Jeffrey F. Eisenberg Esq.
Headquarters: Framingham
Employees: 4
Exchange: NASDAQ

Keep an eye on Xenetic Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Xenetic Biosciences 's (XBIO) price per share?

The current price per share for Xenetic Biosciences (XBIO) is $4.26. The stock has seen a price change of $0.08 recently, indicating a 2.07% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Xenetic Biosciences (XBIO)?

For Xenetic Biosciences (XBIO), the 52-week high is $5.2, which is 21.92% from the current price. The 52-week low is $2.78, the current price is 53.42% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Xenetic Biosciences (XBIO) a growth stock?

Xenetic Biosciences (XBIO) has shown an average price growth of -3.36% over the past three years. It has received a score of 19 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Xenetic Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Xenetic Biosciences (XBIO) stock price performance year to date (YTD)?

As of the latest data, Xenetic Biosciences (XBIO) has a year-to-date price change of 19.64%. Over the past month, the stock has experienced a price change of 14.96%. Over the last three months, the change has been 2.84%. Over the past six months, the figure is 9.39%. Looking at a longer horizon, the five-year price change stands at -63.23%.

help

Is Xenetic Biosciences (XBIO) a profitable company?

Xenetic Biosciences (XBIO) has a net income of -$4.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -184.11% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.54M, with a revenue growth rate of 48.8%, providing insight into the company's sales performance and growth. The gross profit is $2.54M. Operating income is noted at -$4.52M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Xenetic Biosciences (XBIO)?

Xenetic Biosciences (XBIO) has a market capitalization of $6.33M. The average daily trading volume is 4.12, indicating the stock's liquidity and investor engagement.